Cigna Group closed 20.66% short of its 52-week high of $370.83, which the company reached on September 16th.

Icarus Behavioral Health Nevada announces the accreditation of its comprehensive mental health programs in Las Vegas, ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

California is leading the way in ensuring that determinations of medically necessary health care services are made by licensed physicians and ...

CEO David Cordani suggested Thursday that the moves are a direct response to the slaying of UnitedHealthcare CEO Brian Thompson and the public outcry over the state of health care. Other news is on ...

The number of victims impacted by the Change Healthcare data breach last year has nearly doubled, from 100 million to ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 ...

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on Cigna (CI – Research Report), with a price target of ...

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

Shares of Cigna Group slipped 6.70% to $282.98 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.53% to 6,071.17 and the Dow ...

An analysis from health policy charity Kaiser Family Foundation (KFF) evaluated nearly 400million claims made to insurance ...

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.